NEW YORK (GenomeWeb) – GenMark Diagnostics reported after the close of the market on Tuesday that its fourth quarter revenues rose 13 percent year over year.

For the three months ended Dec. 31, the company reported revenues of $14.9 million, up from $13.2 million in Q4 2015, and slightly above analysts' consensus estimate of $14.8 million for the quarter.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.